Prevalence and treatment of cardiovascular disease and traditional risk factors in Australian adults with renal insufficiency
Identifieur interne : 001523 ( Istex/Checkpoint ); précédent : 001522; suivant : 001524Prevalence and treatment of cardiovascular disease and traditional risk factors in Australian adults with renal insufficiency
Auteurs : Esther M. Briganti [Australie] ; Peter G. Kerr ; Jonathan E. Shaw [Australie] ; Paul Z. Zimmet [Australie] ; Robert C. AtkinsSource :
- Nephrology [ 1320-5358 ] ; 2005-02.
English descriptors
- Teeft :
- Australian adults, Australian diabetes, Blood pressure, Briganti, Cardiovascular, Cardiovascular disease, Cardiovascular mortality, Cardiovascular risk factors, Crude prevalence, Diabetes, Diabetes control, Diabetes mellitus, Diabetic nephropathy, Diastolic blood pressure, Excess prevalence, Guideline, High prevalence, Human services, Hyperlipidaemia, Hypertension, Infarction, Intensive control, Kidney disease, Lifestyle study, Lipid, Ltration, Ltration rate, Mellitus, Mmhg, Myocardial infarction, Northern territory, Past history, Physical examination, Present study, Prevalence, Primary prevention, Prospective diabetes study, Renal, Renal disease, Renal function, Renal function categories, Renal impairment, Risk factors, Secondary prevention, Systolic blood pressure, Traditional risk factors, Ukpds.
Abstract
Aim: To evaluate the prevalence and treatment of cardiovascular disease and traditional cardiovascular disease risk factors in Australian adults with renal insufficiency.
Methods: The Australian Diabetes, Obesity and Lifestyle Study was a cross‐sectional survey of Australian adults undertaken in 1999–2000. Participants were categorized based on the Cockcroft–Gault estimated glomerular filtration rate in terms of normal renal function (<60 mL/min per 1.73 m2) and renal insufficiency (<60 mL/min per 1.73 m2). Outcome measures were the prevalence of cardiovascular disease, estimated risk of cardiovascular disease (20% over 10 years) and traditional cardiovascular risk factors, and frequency of pharmacological treatment of traditional cardiovascular risk factors.
Results: Among adults with renal insufficiency, cardiovascular disease was present in 29.4 (95% CI: 25.1–33.6) per 100, with an additional 47.9 (95% CI: 44.9–50.9) per 100 having an estimated risk of cardiovascular disease (20% over 10 years). At least one cardiovascular risk factor was present in 90.1%. Hypertension and type 2 diabetes mellitus were three times more frequent, while hyperlipidaemia was nearly twice as frequent in those participants with renal insufficiency. Of those with renal insufficiency, 58.2% with hypertension were treated, with only 14.5% of this group being treated to current recommended target levels of blood pressure, while only 32.5% with hyperlipidaemia were treated, with 7.4% of this group being treated to target lipid levels.
Conclusion: The present study demonstrates significant scope to reduce the high burden of cardiovascular risk factors in Australian adults with renal insufficiency in the general community, through treatment of traditional risk factors for cardiovascular disease.
Url:
DOI: 10.1111/j.1440-1797.2005.00357.x
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
ISTEX:7E745417826699920744954A4EEAE3690A68B96ALe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Prevalence and treatment of cardiovascular disease and traditional risk factors in Australian adults with renal insufficiency</title><author><name sortKey="Briganti, Esther M" sort="Briganti, Esther M" uniqKey="Briganti E" first="Esther M" last="Briganti">Esther M. Briganti</name></author><author><name sortKey="Kerr, Peter G" sort="Kerr, Peter G" uniqKey="Kerr P" first="Peter G" last="Kerr">Peter G. Kerr</name></author><author><name sortKey="Shaw, Jonathan E" sort="Shaw, Jonathan E" uniqKey="Shaw J" first="Jonathan E" last="Shaw">Jonathan E. Shaw</name></author><author><name sortKey="Zimmet, Paul Z" sort="Zimmet, Paul Z" uniqKey="Zimmet P" first="Paul Z" last="Zimmet">Paul Z. Zimmet</name></author><author><name sortKey="Atkins, Robert C" sort="Atkins, Robert C" uniqKey="Atkins R" first="Robert C" last="Atkins">Robert C. Atkins</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:7E745417826699920744954A4EEAE3690A68B96A</idno><date when="2005" year="2005">2005</date><idno type="doi">10.1111/j.1440-1797.2005.00357.x</idno><idno type="url">https://api.istex.fr/ark:/67375/WNG-MS0DJLHF-S/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">001D39</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001D39</idno><idno type="wicri:Area/Istex/Curation">001D18</idno><idno type="wicri:Area/Istex/Checkpoint">001523</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001523</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Prevalence and treatment of cardiovascular disease and traditional risk factors in Australian adults with renal insufficiency</title><author><name sortKey="Briganti, Esther M" sort="Briganti, Esther M" uniqKey="Briganti E" first="Esther M" last="Briganti">Esther M. Briganti</name><affiliation></affiliation><affiliation wicri:level="1"><country wicri:rule="url">Australie</country></affiliation></author><author><name sortKey="Kerr, Peter G" sort="Kerr, Peter G" uniqKey="Kerr P" first="Peter G" last="Kerr">Peter G. Kerr</name><affiliation><wicri:noCountry code="subField">and</wicri:noCountry></affiliation></author><author><name sortKey="Shaw, Jonathan E" sort="Shaw, Jonathan E" uniqKey="Shaw J" first="Jonathan E" last="Shaw">Jonathan E. Shaw</name><affiliation wicri:level="1"><country xml:lang="fr">Australie</country><wicri:regionArea>International Diabetes Institute, Melbourne, Victoria</wicri:regionArea><wicri:noRegion>Victoria</wicri:noRegion></affiliation></author><author><name sortKey="Zimmet, Paul Z" sort="Zimmet, Paul Z" uniqKey="Zimmet P" first="Paul Z" last="Zimmet">Paul Z. Zimmet</name><affiliation wicri:level="1"><country xml:lang="fr">Australie</country><wicri:regionArea>International Diabetes Institute, Melbourne, Victoria</wicri:regionArea><wicri:noRegion>Victoria</wicri:noRegion></affiliation></author><author><name sortKey="Atkins, Robert C" sort="Atkins, Robert C" uniqKey="Atkins R" first="Robert C" last="Atkins">Robert C. Atkins</name><affiliation><wicri:noCountry code="subField">and</wicri:noCountry></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Nephrology</title><title level="j" type="alt">NEPHROLOGY</title><idno type="ISSN">1320-5358</idno><idno type="eISSN">1440-1797</idno><imprint><biblScope unit="vol">10</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="40">40</biblScope><biblScope unit="page" to="47">47</biblScope><biblScope unit="page-count">8</biblScope><publisher>Blackwell Science Pty</publisher><pubPlace>Melbourne, Australia</pubPlace><date type="published" when="2005-02">2005-02</date></imprint><idno type="ISSN">1320-5358</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1320-5358</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Australian adults</term><term>Australian diabetes</term><term>Blood pressure</term><term>Briganti</term><term>Cardiovascular</term><term>Cardiovascular disease</term><term>Cardiovascular mortality</term><term>Cardiovascular risk factors</term><term>Crude prevalence</term><term>Diabetes</term><term>Diabetes control</term><term>Diabetes mellitus</term><term>Diabetic nephropathy</term><term>Diastolic blood pressure</term><term>Excess prevalence</term><term>Guideline</term><term>High prevalence</term><term>Human services</term><term>Hyperlipidaemia</term><term>Hypertension</term><term>Infarction</term><term>Intensive control</term><term>Kidney disease</term><term>Lifestyle study</term><term>Lipid</term><term>Ltration</term><term>Ltration rate</term><term>Mellitus</term><term>Mmhg</term><term>Myocardial infarction</term><term>Northern territory</term><term>Past history</term><term>Physical examination</term><term>Present study</term><term>Prevalence</term><term>Primary prevention</term><term>Prospective diabetes study</term><term>Renal</term><term>Renal disease</term><term>Renal function</term><term>Renal function categories</term><term>Renal impairment</term><term>Risk factors</term><term>Secondary prevention</term><term>Systolic blood pressure</term><term>Traditional risk factors</term><term>Ukpds</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract">Aim: To evaluate the prevalence and treatment of cardiovascular disease and traditional cardiovascular disease risk factors in Australian adults with renal insufficiency.</div><div type="abstract">Methods: The Australian Diabetes, Obesity and Lifestyle Study was a cross‐sectional survey of Australian adults undertaken in 1999–2000. Participants were categorized based on the Cockcroft–Gault estimated glomerular filtration rate in terms of normal renal function (<60 mL/min per 1.73 m2) and renal insufficiency (<60 mL/min per 1.73 m2). Outcome measures were the prevalence of cardiovascular disease, estimated risk of cardiovascular disease (20% over 10 years) and traditional cardiovascular risk factors, and frequency of pharmacological treatment of traditional cardiovascular risk factors.</div><div type="abstract">Results: Among adults with renal insufficiency, cardiovascular disease was present in 29.4 (95% CI: 25.1–33.6) per 100, with an additional 47.9 (95% CI: 44.9–50.9) per 100 having an estimated risk of cardiovascular disease (20% over 10 years). At least one cardiovascular risk factor was present in 90.1%. Hypertension and type 2 diabetes mellitus were three times more frequent, while hyperlipidaemia was nearly twice as frequent in those participants with renal insufficiency. Of those with renal insufficiency, 58.2% with hypertension were treated, with only 14.5% of this group being treated to current recommended target levels of blood pressure, while only 32.5% with hyperlipidaemia were treated, with 7.4% of this group being treated to target lipid levels.</div><div type="abstract">Conclusion: The present study demonstrates significant scope to reduce the high burden of cardiovascular risk factors in Australian adults with renal insufficiency in the general community, through treatment of traditional risk factors for cardiovascular disease.</div></front></TEI><affiliations><list><country><li>Australie</li></country></list><tree><noCountry><name sortKey="Atkins, Robert C" sort="Atkins, Robert C" uniqKey="Atkins R" first="Robert C" last="Atkins">Robert C. Atkins</name><name sortKey="Kerr, Peter G" sort="Kerr, Peter G" uniqKey="Kerr P" first="Peter G" last="Kerr">Peter G. Kerr</name></noCountry><country name="Australie"><noRegion><name sortKey="Briganti, Esther M" sort="Briganti, Esther M" uniqKey="Briganti E" first="Esther M" last="Briganti">Esther M. Briganti</name></noRegion><name sortKey="Shaw, Jonathan E" sort="Shaw, Jonathan E" uniqKey="Shaw J" first="Jonathan E" last="Shaw">Jonathan E. Shaw</name><name sortKey="Zimmet, Paul Z" sort="Zimmet, Paul Z" uniqKey="Zimmet P" first="Paul Z" last="Zimmet">Paul Z. Zimmet</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Lorraine/explor/InforLorV4/Data/Istex/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001523 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd -nk 001523 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Lorraine
|area= InforLorV4
|flux= Istex
|étape= Checkpoint
|type= RBID
|clé= ISTEX:7E745417826699920744954A4EEAE3690A68B96A
|texte= Prevalence and treatment of cardiovascular disease and traditional risk factors in Australian adults with renal insufficiency
}}
| This area was generated with Dilib version V0.6.33. |  |